Angela Mastronuzzi
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Angela Mastronuzzi
Jul 26, 2024, 00:01 |
Insight
Angela Mastronuzzi: Editorial 2021 WHO classification of pediatric brain tumors
Angela Mastronuzzi shared on LinkedIn: “Editorial: 2021 WHO classification of pediatric brain tumors: a final…
Jul 25, 2024, 21:45 |
Insight
Angela Mastronuzzi: Gliomatosis cerebri in children
Angela Mastronuzzi shared on LinkedIn a recent paper by Gunther Nussbaumer et al. titled "Gliomatosis…
Jul 18, 2024, 22:39 |
Blog
Angela Mastronuzzi: GD2-Targeting therapy for GD2+ Medulloblastoma
Angela Mastronuzzi shared a post on LinkedIn: ''GD2-Targeting CAR T-cell Therapy for Patients with GD2+…
Jul 14, 2024, 12:19 |
Blog
Angela Mastronuzzi: Ospedale Pediatrico Bambino Gesu’s team at the ISPNO2024
Angela Mastronuzzi posted on LinkedIn: "I am extremely proud of my team for representing Ospedale…
Jun 8, 2024, 09:47 |
Blog
Angela Mastronuzzi: Today and every June 8th, we honor World Brain Tumor Day
Angela Mastronuzzi shared a post on LinkedIn: “Today and every June 8th, we honor World Brain…
Jun 2, 2024, 09:12 |
Blog
Mission Brain Unicatt - Introducing Gemelli NeuroChronicle
Mission Brain Unicatt shared a post on LinkedIn: " Introducing 'Gemelli NeuroChronicle (GNC)' !!! Our first…
May 20, 2024, 11:53 |
Insight
Angela Mastronuzzi: The annual ceremony to support the scientific-research of the Umberto Veronesi ETS Foundation in Milan
Angela Mastronuzzi shared on LinkedIn: “A wonderful day at the annual ceremony to support the scientific-research…
May 18, 2024, 00:51 |
Blog
Angela Mastronuzzi: Diffuse Intrinsic Pontine Glioma Awareness Day
Angela Mastronuzzi shared on LinkedIn: "Today is DIPG Awareness Day, which occurs annually on May 17th,…
May 15, 2024, 14:48 |
Blog
Angela Mastronuzzi: I had the pleasure to speak at SIOP Europe
Angela Mastronuzzi shared on LinkedIn: "Yesterday, I had the pleasure to speak at SIOP Europe, the…
May 1, 2024, 11:43 |
Blog
Angela Mastronuzzi: We dedicate May to brain tumor education
Angela Mastronuzzi shared on LinkedIn: "Today begins Brain Tumor Awareness Month. We dedicate May to…
May 1, 2024, 00:59 |
Insight
Angela Mastronuzzi: Yet another impactful and giant step in clinical research
Angela Mastronuzzi shared on LinkedIn: "Also out with The NEW ENGLAND JOURNAL of MEDICINE of the NEJM Group:…
Apr 26, 2024, 12:05 |
Blog
The final day of GIORNATE AIEOP 2024!
AIEOP: Italian Association of Pediatric Hematology and Oncology shared on LinkedIn: "That concludes the final…
Apr 23, 2024, 21:29 |
Blog
Angela Mastronuzzi: I spoke at the 'New evidence in the integrated management of neuro-oncology adult and pediatric patients' congress
Angela Mastronuzzi shared on LinkedIn: "Saturday I spoke at the 'New evidence in the integrated…
Apr 22, 2024, 17:31 |
Blog
Angela Mastronuzzi: A trip to the vibrant Memphis for Posterior Fossa Society's global meeting!
Angela Mastronuzzi shared on LinkedIn: "A trip to the vibrant Memphis for Posterior Fossa Society's global…
Apr 21, 2024, 18:21 |
Career
Angela Mastronuzzi: I look forward to speaking at the award ceremony of the G. Toniolo Institute of Higher Studies
Angela Mastronuzzi shared a post on LinkedIn: “SAVE THE DATE! AWARDS CEREMONY SMART SCHOLARSHIPS and…
Apr 20, 2024, 16:57 |
Societies
Angela Mastronuzzi: "Primary CNS tumors: A pragmatic approach to the diagnosis keeping an eye to the future" was a success!
Angela Mastronuzzi shared a post on LinkedIn: '"Primary CNS tumors: a pragmatic approach to the diagnosis…
Apr 17, 2024, 12:19 |
Blog
Angela Mastronuzzi: Special Collection on 'Pediatric Precision Oncology: Target Therapy/New Drugs in Pediatric Brain Tumors'
Angela Mastronuzzi, Head of Neuro-Oncology Unit at Bambino Gesù Children's Hospital, shared a post on…
Apr 16, 2024, 01:52 |
Insight
,
Opinion
Angela Mastronuzzi: We investigated whether CAR T-cells directed towards the disialoganglioside GD2 can represent a potentially more effective treatment with reduced long-term side effects
Apr 15, 2024, 13:41 |
Blog
Angela Mastronuzzi: New evidence in the integrated management of neuro-oncology adult and pediatric patients
Angela Mastronuzzi shared on LinkedIn: “‘New evidence in the integrated management of neuro-oncology adult and pediatric…
Apr 12, 2024, 08:11 |
Blog
Angela Mastronuzzi: The necessity to adopt the new classification when considering therapeutic options
Angela Mastronuzzi shared a post on LinkedIn: "Our recently published paper is out with Frontiers!…
Mar 12, 2024, 09:51 |
Blog
Angela Mastronuzzi: Happy to share our multicenter retrospective study on a large cohort of GBM-LTS patients from nine Italian institutions
Angela Mastronuzzi shared on LinkedIn: “Happy to share our just published study! "Clinicopathological and molecular landscape…
Mar 3, 2024, 02:04 |
Blog
Angela Mastronuzzi: Primary CNS Tumours Course
Angela Mastronuzzi shared on LinkedIn: "'PRIMARY CNS TUMOURS: A PRAGMATIC APPROACH TO THE DIAGNOSIS KEEPING AN…
Jan 20, 2024, 16:32 |
Career
Angela Mastronuzzi: Ten open positions for a research project
Angela Mastronuzzi shared on LinkedIn: ''I'm hiring! Ten open positions for the research project entitled…
Jan 19, 2024, 13:54 |
Insight
Angela Mastronuzzi: A review on the main characteristics of neonatal CNS tumours and the recent advances in their treatment
Angela Mastronuzzi shared on LinkedIn: "Published with European Journal of Pediatrics: 'Central nervous system tumours…
Jan 9, 2024, 18:56 |
Blog
Angela Mastronuzzi: Our Letter to the Editor is out with Child's Nervous System journal
Angela Mastronuzzi shared a post on LinkedIn: "Our Letter to the Editor is out with…
Dec 30, 2023, 17:22 |
Blog
Angela Mastronuzzi: I have been selected as a candidate for the Women Leaders in Paediatric Oncology Network Co-Chair of SIOP!
Angela Mastronuzzi shared a post on LinkedIn: "I am delighted to announce I have been…
Dec 7, 2023, 18:58 |
Insight
Angela Mastronuzzi: A bibliometric analysis of the publications on AI tools for pediatric brain tumors
Angela Mastronuzzi recently shared on LinkedIn: "Our review has just been published with Frontiers! We…
Nov 26, 2023, 17:11 |
Insight
Angela Mastronuzzi: To our knowledge this is the largest reported pediatric series with use of virtual reality for tumor resection
Angela Mastronuzzi shared on LinkedIn: "Our Letters to the Editor is out with the Journal of Neurosurgical…
Nov 19, 2023, 00:05 |
Blog
Angela Mastronuzzi: Our aim was to evaluate the feasibility of VEN plus Cy-Topo in children with relapsed/refractory neuroblastoma
Angela Mastronuzzi, Head of Neuro-Oncology Unit at the Bambino Gesù Children’s Hospital, shared on LinkedIn:…
Oct 25, 2023, 18:20 |
Blog
Angela Mastronuzzi: Our data strongly support the favourable therapeutic profile of PBT for the treatment of CNS germ cell tumors
Angela Mastronuzzi shared on LinkedIn: ''Our latest paper is out with Frontiers! "Unraveling the impact of…
Oct 8, 2023, 18:03 |
Blog
Angela Mastronuzzi: AIEOP2023 has concluded and I have so many people to thank!
Angela Mastronuzzi shared on LinkedIn: “AIEOP2023 has concluded and I have so many people to thank!…
Sep 27, 2023, 18:21 |
Blog
Angela Mastronuzzi: Call for Abstracts!
Quoting Angela Mastronuzzi on LinkedIn: “CALL FOR ABSTRACTS! Proud to announce that I will be serving…
Sep 22, 2023, 18:38 |
Insight
Angela Mastronuzzi: Proud of my team at Ospedale Pediatrico Bambino Gesù for this paper published with MDPI.
Angela Mastronuzzi, Head of Neuro-Oncology Unit at the Bambino Gesù Children's Hospital, shared on LinkedIn:…
Sep 21, 2023, 04:22 |
Blog
Angela Mastronuzzi: 2023 AIEOP Congress. Don't miss this opportunity!
Angela Mastronuzzi, Head of Neuro-Oncology Unit at Bambino Gesù Children's Hospital, recently shared on LinkedIn: "2023…
Sep 16, 2023, 18:50 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 4
Three weeks ago, OncoDaily initiated its series on '100 Influential Women in Oncology: Key Opinion…
Sep 8, 2023, 19:03 |
Insight
Angela Mastronuzzi: Our Ospedale Pediatrico Bambino Gesù team's recently published paper with Nature Communications by Nature Portfolio is out.
Angela Mastronuzzi, Head of Neuro-Oncology Unit at Bambino Gesù Children's Hospital, recently posted on LinkedIn:…
Sep 2, 2023, 18:55 |
Insight
Angela Mastronuzzi: This literature review shows that targeted therapy is a feasible approach for pediatric low-grade gliomas.
Quoting Angela Mastronuzzi, Head of Neuro-Oncology Unit at the Bambino Gesù Children's Hospital on LinkedIn:…
Aug 23, 2023, 14:40 |
Insight
Angela Mastronuzzi: Quality of life in childhood cancer survivors is largely affected by survivorship care and transition from treatment to long-term follow-up.
Quting Angela Mastronuzzi, the Head of Neuro-Oncology Unit at Bambino Gesù Children's Hospital, on LinkedIn:…
Aug 15, 2023, 18:34 |
Insight
Angela Mastronuzzi: I am proud to present our recently published paper - "The Italian version of the Pediatric Quality of Life Inventory™ (PEDSQL™) 3.0 healthcare satisfaction hematology/oncology module: reliability and validity in radiation oncology"
All:
39
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube